Never abruptly discontinue NUCYNTA ER in a very affected person physically depending on opioids. When discontinuing NUCYNTA ER inside a bodily dependent affected person, step by step taper the dosage. Rapid tapering of tapentadol within a patient bodily dependent on opioids may possibly result in a withdrawal syndrome and return https://eminemo122nwh4.blog4youth.com/profile